346 related articles for article (PubMed ID: 8782457)
1. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice.
Neurath MF; Pettersson S; Meyer zum Büschenfelde KH; Strober W
Nat Med; 1996 Sep; 2(9):998-1004. PubMed ID: 8782457
[TBL] [Abstract][Full Text] [Related]
2. Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation.
Neurath MF; Pettersson S
Immunobiology; 1997 Dec; 198(1-3):91-8. PubMed ID: 9442381
[TBL] [Abstract][Full Text] [Related]
3. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.
Lawrance IC; Wu F; Leite AZ; Willis J; West GA; Fiocchi C; Chakravarti S
Gastroenterology; 2003 Dec; 125(6):1750-61. PubMed ID: 14724828
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.
Murano M; Maemura K; Hirata I; Toshina K; Nishikawa T; Hamamoto N; Sasaki S; Saitoh O; Katsu K
Clin Exp Immunol; 2000 Apr; 120(1):51-8. PubMed ID: 10759763
[TBL] [Abstract][Full Text] [Related]
5. [The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis].
Gan H; Ouyang Q; Chen Y; Liang F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):268-72. PubMed ID: 12856595
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB p65 antisense oligonucleotides may serve as a novel molecular approach for the treatment of patients with ulcerative colitis.
Li Z; Zhang DK; Yi WQ; Ouyang Q; Chen YQ; Gan HT
Arch Med Res; 2008 Nov; 39(8):729-34. PubMed ID: 18996285
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of intestinal fibrosis?
Macdonald TT
Gastroenterology; 2003 Dec; 125(6):1889-92. PubMed ID: 14724843
[No Abstract] [Full Text] [Related]
8. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis.
Segain JP; Raingeard de la Blétière D; Sauzeau V; Bourreille A; Hilaret G; Cario-Toumaniantz C; Pacaud P; Galmiche JP; Loirand G
Gastroenterology; 2003 May; 124(5):1180-7. PubMed ID: 12730857
[TBL] [Abstract][Full Text] [Related]
9. Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides.
Spiik AK; Ridderstad A; Axelsson LG; Midtvedt T; Björk L; Pettersson S
Int J Colorectal Dis; 2002 Jul; 17(4):223-32. PubMed ID: 12073070
[TBL] [Abstract][Full Text] [Related]
10. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
12. A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation.
McIntyre KW; Lombard-Gillooly K; Perez JR; Kunsch C; Sarmiento UM; Larigan JD; Landreth KT; Narayanan R
Antisense Res Dev; 1993; 3(4):309-22. PubMed ID: 8155973
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.
Sokoloski JA; Sartorelli AC; Rosen CA; Narayanan R
Blood; 1993 Jul; 82(2):625-32. PubMed ID: 8101106
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
15. Tackling the real culprits in Crohn's disease.
Bonn D
Lancet; 1998 Jun; 351(9117):1710. PubMed ID: 9734899
[No Abstract] [Full Text] [Related]
16. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.
Neurath MF; Fuss I; Schürmann G; Pettersson S; Arnold K; Müller-Lobeck H; Strober W; Herfarth C; Büschenfelde KH
Ann N Y Acad Sci; 1998 Nov; 859():149-59. PubMed ID: 9928378
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis.
Wu F; Chakravarti S
J Immunol; 2007 Nov; 179(10):6988-7000. PubMed ID: 17982090
[TBL] [Abstract][Full Text] [Related]
19. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.
Izzo R; Bevivino G; De Simone V; Sedda S; Monteleone I; Marafini I; Di Giovangiulio M; Rizzo A; Franzè E; Colantoni A; Ortenzi A; Monteleone G
Inflamm Bowel Dis; 2018 May; 24(6):1213-1224. PubMed ID: 29668937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
